61. Outpatient COVID-19 Therapy with Salim Rezaie, MD

<p><span style="font-weight: 400;">The treatment of non-hospitalized patients suffering from COVID-19 is a hot topic and constantly changing. Today we have a conversation with</span> <a href= "https://twitter.com/srrezaie?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor"> <span style="font-weight: 400;">Salim Rezaie, MD</span></a> <span style="font-weight: 400;">whose dive into this literature couldn’t be much deeper. We discuss which subgroup of patients might benefit from monoclonal antibodies, why the jury is still out on the benefit of ivermectin, the role of inhaled budesonide, and outpatient anticoagulation which hasn’t been studied, but hopefully will be someday.</span></p> <p><span style="font-weight: 400;">Listen on:</span></p> <ul> <li style="font-weight: 400;" aria-level="1"><a href= "https://podcasts.apple.com/us/podcast/stimulus/id1501107371"><strong> iTunes</strong></a></li> <li style="font-weight: 400;" aria-level="1"><a href= "https://open.spotify.com/show/0w6oFNiT8P1kPWyivim0G0"><strong>Spotify</strong></a></li> <li style="font-weight: 400;" aria-level="1"><a href= "https://www.stitcher.com/podcast/stimulus"><strong>Stitcher</strong></a></li> </ul> <p> </p> <p><strong>Guest Bio:</strong><span style= "font-weight: 400;"> </span> <span style= "font-weight: 400;">Salim Rezaie completed his medical school training at Texas A&M Health Science Center and continued his medical education with a combined Emergency Medicine/Internal Medicine residency at East Carolina University.  He currently works as a community emergency physician at Greater San Antonio Emergency Physicians (GSEP) where he is the director of clinical education.  Salim is the creator and founder of</span> <a href="https://rebelem.com/"><span style= "font-weight: 400;">REBEL EM</span></a> <span style= "font-weight: 400;">and</span> <a href= "https://rebelem.com/rebel-cast/"><span style= "font-weight: 400;">REBEL Cast</span></a><span style= "font-weight: 400;">, a free, critical appraisal blog and podcast that tries to cut down knowl